P3 HEALTH PARTNERS INC (PIII)
US7444131053 - Common Stock
Overall PIII gets a fundamental rating of 1 out of 10. We evaluated PIII against 107 industry peers in the Health Care Providers & Services industry. PIII has a bad profitability rating. Also its financial health evaluation is rather negative. PIII is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PIII has reported negative net income.
PIII had a negative operating cash flow in the past year.
PIII had negative earnings in each of the past 5 years.
In the past 5 years PIII always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -12.32%, PIII is doing worse than 73.33% of the companies in the same industry.
The Return On Equity of PIII (-85.21%) is worse than 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.32% | ||
| ROE | -85.21% | ||
| ROIC | N/A |
ROA(3y)-14.71%
ROA(5y)-27.73%
ROE(3y)-1558.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for PIII so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
PIII does not have a ROIC to compare to the WACC, probably because it is not profitable.
PIII has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, PIII has a worse debt to assets ratio.
2.2 Solvency
PIII has an Altman-Z score of -0.15. This is a bad value and indicates that PIII is not financially healthy and even has some risk of bankruptcy.
PIII's Altman-Z score of -0.15 is on the low side compared to the rest of the industry. PIII is outperformed by 76.19% of its industry peers.
A Debt/Equity ratio of 1.11 is on the high side and indicates that PIII has dependencies on debt financing.
PIII's Debt to Equity ratio of 1.11 is on the low side compared to the rest of the industry. PIII is outperformed by 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.15 |
ROIC/WACCN/A
WACC7.55%
2.3 Liquidity
PIII has a Current Ratio of 0.53. This is a bad value and indicates that PIII is not financially healthy enough and could expect problems in meeting its short term obligations.
PIII has a worse Current ratio (0.53) than 89.52% of its industry peers.
A Quick Ratio of 0.53 indicates that PIII may have some problems paying its short term obligations.
The Quick ratio of PIII (0.53) is worse than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 71.75% over the past year.
Looking at the last year, PIII shows a very strong growth in Revenue. The Revenue has grown by 25.37%.
PIII shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 70.57% yearly.
EPS 1Y (TTM)71.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.67%
Revenue 1Y (TTM)25.37%
Revenue growth 3Y37.65%
Revenue growth 5Y70.57%
Sales Q2Q%25.58%
3.2 Future
Based on estimates for the next years, PIII will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.27% on average per year.
The Revenue is expected to grow by 10.95% on average over the next years. This is quite good.
EPS Next Y-1.61%
EPS Next 2Y17.65%
EPS Next 3Y10.27%
EPS Next 5YN/A
Revenue Next Year23.34%
Revenue Next 2Y10.41%
Revenue Next 3Y10.95%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
PIII reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PIII. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.65%
EPS Next 3Y10.27%
5. Dividend
5.1 Amount
No dividends for PIII!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
P3 HEALTH PARTNERS INC
NASDAQ:PIII (1/6/2025, 3:52:39 PM)
0.245
0 (-1.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners23.63%
Inst Owner Change0%
Ins Owners3.18%
Ins Owner Change0%
Market Cap87.91M
Analysts80
Price Target0.77 (214.29%)
Short Float %0.58%
Short Ratio1.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-367.32%
Min EPS beat(2)-658.17%
Max EPS beat(2)-76.47%
EPS beat(4)0
Avg EPS beat(4)-219.44%
Min EPS beat(4)-658.17%
Max EPS beat(4)-47.05%
EPS beat(8)3
Avg EPS beat(8)-109.32%
EPS beat(12)5
Avg EPS beat(12)-79.65%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-3.06%
Max Revenue beat(2)-2.59%
Revenue beat(4)2
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)12.24%
Revenue beat(8)5
Avg Revenue beat(8)2.74%
Revenue beat(12)7
Avg Revenue beat(12)5.11%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-69.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-312.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-125.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.06 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.76
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS4.12
BVpS0.34
TBVpS-1.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.32% | ||
| ROE | -85.21% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-14.71%
ROA(5y)-27.73%
ROE(3y)-1558.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 0.25% | ||
| Cap/Sales | 0.01% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | -0.15 |
F-Score3
WACC7.55%
ROIC/WACCN/A
Cap/Depr(3y)14.57%
Cap/Depr(5y)154.5%
Cap/Sales(3y)0.3%
Cap/Sales(5y)0.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-141.67%
EPS Next Y-1.61%
EPS Next 2Y17.65%
EPS Next 3Y10.27%
EPS Next 5YN/A
Revenue 1Y (TTM)25.37%
Revenue growth 3Y37.65%
Revenue growth 5Y70.57%
Sales Q2Q%25.58%
Revenue Next Year23.34%
Revenue Next 2Y10.41%
Revenue Next 3Y10.95%
Revenue Next 5YN/A
EBIT growth 1Y-39.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.72%
EBIT Next 3Y30.82%
EBIT Next 5YN/A
FCF growth 1Y44.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.03%
OCF growth 3YN/A
OCF growth 5YN/A